Cited by

• LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads.

  Böhm HJ. Böhm HJ. J Comput Aided Mol Des. 1992 Dec;6(6):593-606. doi: 10.1007/BF00126217. J Comput Aided Mol Des. 1992. PMID: 1291628
• Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease.

  Bilello JA, Bilello PA, Stellrecht K, Leonard J, Norbeck DW, Kempf DJ, Robins T, Drusano GL. Bilello JA, et al. Antimicrob Agents Chemother. 1996 Jun;40(6):1491-7. doi: 10.1128/AAC.40.6.1491. Antimicrob Agents Chemother. 1996. PMID: 8726025 Free PMC article.
• Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.

  Maryanoff BE, Qiu X, Padmanabhan KP, Tulinsky A, Almond HR Jr, Andrade-Gordon P, Greco MN, Kauffman JA, Nicolaou KC, Liu A, et al. Maryanoff BE, et al. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8048-52. doi: 10.1073/pnas.90.17.8048. Proc Natl Acad Sci U S A. 1993. PMID: 8367461 Free PMC article.
• 3'-Tetrahydrofuranylglycine as a Novel, Unnatural Amino Acid Surrogate for Asparagine in the Design of Inhibitors of the HIV Protease.

  Thompson WJ, Ghosh AK, Holloway MK, Lee HY, Munson PM, Schwering JE, Wai J, Darke PL, Zugay J, Emini EA, Schleif WA, Huff JR, Anderson PS. Thompson WJ, et al. J Am Chem Soc. 1993 Jan 1;115(2):801-803. doi: 10.1021/ja00055a069. J Am Chem Soc. 1993. PMID: 30364398 Free PMC article.
• Estimate of the frequency of human immunodeficiency virus type 1 protease inhibitor resistance within unselected virus populations in vitro.

  Tucker SP, Stiebel TR Jr, Potts KE, Smidt ML, Bryant ML. Tucker SP, et al. Antimicrob Agents Chemother. 1998 Feb;42(2):478-80. doi: 10.1128/AAC.42.2.478. Antimicrob Agents Chemother. 1998. PMID: 9527815 Free PMC article.